RU2020126673A3 - - Google Patents

Download PDF

Info

Publication number
RU2020126673A3
RU2020126673A3 RU2020126673A RU2020126673A RU2020126673A3 RU 2020126673 A3 RU2020126673 A3 RU 2020126673A3 RU 2020126673 A RU2020126673 A RU 2020126673A RU 2020126673 A RU2020126673 A RU 2020126673A RU 2020126673 A3 RU2020126673 A3 RU 2020126673A3
Authority
RU
Russia
Application number
RU2020126673A
Other languages
Russian (ru)
Other versions
RU2020126673A (ru
RU2787993C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2020126673A publication Critical patent/RU2020126673A/ru
Publication of RU2020126673A3 publication Critical patent/RU2020126673A3/ru
Application granted granted Critical
Publication of RU2787993C2 publication Critical patent/RU2787993C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
RU2020126673A 2018-01-10 2019-01-09 Комбинированные терапии для лечения гепатоцеллюлярной карциномы RU2787993C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862615848P 2018-01-10 2018-01-10
US62/615,848 2018-01-10
PCT/US2019/012886 WO2019139977A1 (en) 2018-01-10 2019-01-09 Combination therapies for the treatment of hepatocellular carcinoma

Publications (3)

Publication Number Publication Date
RU2020126673A RU2020126673A (ru) 2022-02-10
RU2020126673A3 true RU2020126673A3 (https=) 2022-04-19
RU2787993C2 RU2787993C2 (ru) 2023-01-16

Family

ID=

Also Published As

Publication number Publication date
US20200360371A1 (en) 2020-11-19
US11833119B2 (en) 2023-12-05
CN111787922A (zh) 2020-10-16
MX2020007375A (es) 2020-11-09
JP2023175825A (ja) 2023-12-12
JP7665700B2 (ja) 2025-04-21
RU2020126673A (ru) 2022-02-10
WO2019139977A1 (en) 2019-07-18
KR20250073570A (ko) 2025-05-27
KR20200121302A (ko) 2020-10-23
AU2019206480A1 (en) 2020-08-27
MA51570A (fr) 2020-11-18
EP3737377A1 (en) 2020-11-18
SG11202006617RA (en) 2020-08-28
BR112020014112A2 (pt) 2020-12-01
IL275981A (en) 2020-08-31
JP7352569B2 (ja) 2023-09-28
CA3088292A1 (en) 2019-07-18
EP4667005A2 (en) 2025-12-24
JP2021512140A (ja) 2021-05-13
EP3737377B1 (en) 2025-10-08
KR102811519B1 (ko) 2025-05-22
EP4667005A3 (en) 2026-02-18

Similar Documents

Publication Publication Date Title
BR112021012222A2 (https=)
BR112021000792B8 (https=)
BR122022015534A2 (https=)
BR122022002075A2 (https=)
AT524834A2 (https=)
AT521543A3 (https=)
AT524266A2 (https=)
BR122022005529A2 (https=)
BR122022016585A2 (https=)
BR212020012832U2 (https=)
BR202018071071U8 (https=)
BR202018008879U2 (https=)
BR202018007669U2 (https=)
BR202018006247U2 (https=)
BR202018004136U2 (https=)
BR202018002487U2 (https=)
BR202018002069U2 (https=)
CN304434539S (https=)
CN304434110S (https=)
CN304388867S9 (https=)
CN304267588S9 (https=)
CN304201967S8 (https=)
CN303588531S9 (https=)
CN303584708S8 (https=)
CN303562894S9 (https=)